Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30-positive aggressive lymphomas.

Sandro Wagner; Thomas Melchardt; Alexander Egle; Teresa Magnes; Cathrin Skrabs; Philipp Staber; Ingrid Simonitsch-Klupp; Michael Panny; Barbara Lehner; Richard Greil; Felix Keil; Ulrich Jäger; Christian Sillaber

doi:10.1111/ejh.13368

Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30-positive aggressive lymphomas.

Sandro Wagner (First author), Thomas Melchardt (Co-author), Alexander Egle (Co-author), Teresa Magnes (Co-author), Cathrin Skrabs, Philipp Staber, Ingrid Simonitsch-Klupp, Michael Panny, Barbara Lehner, Richard Greil (Co-author), Felix Keil, Ulrich Jäger, Christian Sillaber

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article (Journal) › peer-review

12 Citations (Web of Science)

Original language	English
Pages (from-to)	251-258
Journal	EUROPEAN JOURNAL OF HAEMATOLOGY
Volume	104
Issue number	3
DOIs	https://doi.org/10.1111/ejh.13368
Publication status	Published - 2020

Keywords

STEM-CELL TRANSPLANTATION
PHASE-II TRIAL
HODGKIN
MULTICENTER
CHEMOTHERAPY
ETOPOSIDE
THERAPY
PROGRAM

Access to Document

10.1111/ejh.13368

Cite this

Wagner, S., Melchardt, T., Egle, A., Magnes, T., Skrabs, C., Staber, P., Simonitsch-Klupp, I., Panny, M., Lehner, B., Greil, R., Keil, F., Jäger, U., & Sillaber, C. (2020). Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30-positive aggressive lymphomas. EUROPEAN JOURNAL OF HAEMATOLOGY , 104(3), 251-258. https://doi.org/10.1111/ejh.13368

Wagner, Sandro ; Melchardt, Thomas ; Egle, Alexander et al. / Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30-positive aggressive lymphomas. In: EUROPEAN JOURNAL OF HAEMATOLOGY 2020 ; Vol. 104, No. 3. pp. 251-258.

@article{b4c0ea632f80412d8a5b78ab5b661a4d,

title = "Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30-positive aggressive lymphomas.",

keywords = "STEM-CELL TRANSPLANTATION, PHASE-II TRIAL, HODGKIN, MULTICENTER, CHEMOTHERAPY, ETOPOSIDE, THERAPY, PROGRAM",

author = "Sandro Wagner and Thomas Melchardt and Alexander Egle and Teresa Magnes and Cathrin Skrabs and Philipp Staber and Ingrid Simonitsch-Klupp and Michael Panny and Barbara Lehner and Richard Greil and Felix Keil and Ulrich J{\"a}ger and Christian Sillaber",

note = "Wagner, Melchardt, Egle, Magnes, Greil: Paracelsus Med Univ Salzburg, Med Dept Hematol & Med Oncol 3, Salzburg, Austria;",

year = "2020",

doi = "10.1111/ejh.13368",

language = "English",

volume = "104",

pages = "251--258",

journal = "EUROPEAN JOURNAL OF HAEMATOLOGY ",

issn = "0902-4441",

number = "3",

}

Wagner, S , Melchardt, T , Egle, A , Magnes, T, Skrabs, C, Staber, P, Simonitsch-Klupp, I, Panny, M, Lehner, B, Greil, R, Keil, F, Jäger, U & Sillaber, C 2020, 'Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30-positive aggressive lymphomas.', EUROPEAN JOURNAL OF HAEMATOLOGY , vol. 104, no. 3, pp. 251-258. https://doi.org/10.1111/ejh.13368

Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30-positive aggressive lymphomas. / Wagner, Sandro (First author); Melchardt, Thomas (Co-author); Egle, Alexander (Co-author) et al.
In: EUROPEAN JOURNAL OF HAEMATOLOGY , Vol. 104, No. 3, 2020, p. 251-258.

Research output: Contribution to journal › Original Article (Journal) › peer-review

TY - JOUR

T1 - Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30-positive aggressive lymphomas.

AU - Wagner, Sandro

AU - Melchardt, Thomas

AU - Egle, Alexander

AU - Magnes, Teresa

AU - Skrabs, Cathrin

AU - Staber, Philipp

AU - Simonitsch-Klupp, Ingrid

AU - Panny, Michael

AU - Lehner, Barbara

AU - Greil, Richard

AU - Keil, Felix

AU - Jäger, Ulrich

AU - Sillaber, Christian

N1 - Wagner, Melchardt, Egle, Magnes, Greil: Paracelsus Med Univ Salzburg, Med Dept Hematol & Med Oncol 3, Salzburg, Austria;

PY - 2020

Y1 - 2020

KW - STEM-CELL TRANSPLANTATION

KW - PHASE-II TRIAL

KW - HODGKIN

KW - MULTICENTER

KW - CHEMOTHERAPY

KW - ETOPOSIDE

KW - THERAPY

KW - PROGRAM

U2 - 10.1111/ejh.13368

DO - 10.1111/ejh.13368

M3 - Original Article (Journal)

C2 - 31838747

SN - 0902-4441

VL - 104

SP - 251

EP - 258

JO - EUROPEAN JOURNAL OF HAEMATOLOGY

JF - EUROPEAN JOURNAL OF HAEMATOLOGY

IS - 3

ER -

Wagner S , Melchardt T , Egle A , Magnes T, Skrabs C, Staber P et al. Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30-positive aggressive lymphomas. EUROPEAN JOURNAL OF HAEMATOLOGY . 2020;104(3):251-258. doi: 10.1111/ejh.13368